Please note: The information displayed on this page might be outdated.
Vivoryon: Vivoryon Therapeutics has two decades of successful history in bringing pharmaceutical innovation to patients in need. Vivoryon's programs are based on dedicated research, top-level discovery and determined development. The company develops first-in-class medicines that target post-translational modifying enzymes. The pipeline contains several product candidates across various stages of development, focused on Alzheimer’s Disease and oncology.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll
Disease Space
Central Nervous System
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Small Molecule
Website:
Address:
Weinbergweg 22
Halle/Saale, 06120
Germany

Company Participants at BIO CEO & Investor Conference

  • Konrad Glund, PhD, Chief Executive Officer

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.